Stockreport

Cyclo Therapeutics to Present at the 21st Annual WORLDSymposium™ 2025

Cyclo Therapeutics, Inc.  (CYTH) 
PDF Pivotal Phase 3 global study (TransportNPC™) evaluating Trappsol® Cyclo™ for Niemann-Pick Disease Type C1 (“NPC1”) to be highlighted in an oral presentation GAINESVIL [Read more]